Oct 16, 2026 07:01AM
Aug 3, 2026 07:09AM
Jun 16, 2026 08:01AM
Jun 15, 2026 06:05AM
Apr 29, 2026 09:08AM
Apr 27, 2026 08:47AM
Feb 23, 2026 08:31AM Adial Pharmaceuticals notes FDA policy shift on trial requirements
Dec 12, 2025 04:17PM
Nov 26, 2025 08:01AM
Nov 14, 2025 04:25PM
Oct 9, 2025 08:32AM
Sep 30, 2025 07:38AM
Sep 3, 2025 08:30AM
Aug 20, 2025 08:31AM Adial Pharmaceuticals welcomes senate support for AUD trial endpoints
Aug 6, 2025 08:02AM
Jul 9, 2025 08:32AM
Jun 25, 2025 08:35AM
Jun 17, 2025 08:02AM
Jun 11, 2025 08:01AM
May 30, 2025 04:14PM
May 8, 2025 08:30AM Adial Pharmaceuticals (ADIL) Granted End of Phase 2 Meeting from the FDDA
May 2, 2025 11:49AM
May 1, 2025 08:32AM
Mar 4, 2025 09:59AM
Feb 25, 2025 09:01AM
Feb 19, 2025 09:02AM
Feb 12, 2025 09:01AM
Jan 29, 2025 09:02AM Adial Pharmaceuticals (ADIL) Announces Positive Clinical Study Results from the AD04-103 Pharmacokinetics Study of AD04 for the Treatment of Alcohol Use Disorder
Dec 3, 2024 08:31AM
Nov 14, 2024 08:40AM
Nov 14, 2024 06:38AM
Nov 5, 2024 08:30AM
Oct 17, 2024 09:03AM
Sep 19, 2024 08:31AM
Aug 13, 2024 09:03AM Adial Pharmaceuticals (ADIL) Signs Agreement with Boudicca Dx to Advance Regulatory Strategy for Companion Diagnostic Genetic Test for AD04
Jul 31, 2024 08:32AM

479,045 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All